HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics

More filters

Study design
Intervention type
Study phase
289studies shown
Showing 1-12 of 289
Other study type icon
RecruitingNCT01248767

Care pathways for people seeking help for behavioral addictions

About this title

A Prospective Clinical Study of a Cohort of Patients Seeking Treatment for a Behavioral Addiction

Read the official source — NCT01248767
Official study title

A Prospective Clinical Study of a Cohort of Pathological Patients Seeking Treatment for a Behavioral Addiction in the University Hospital of Nantes

Recruiting in France
AddictionObservational studyAges 15+
Countries
France
Sponsor
Nantes University Hospital
Drug study icon
RecruitingNCT05511363

KarXT or placebo to prevent relapse of psychosis linked to Alzheimer’s disease

About this titleRead the official source — NCT05511363
Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Recruiting in France
SchizophreniaMedication studyAges 55–90
Countries
France, United States, United Kingdom, + 10 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingNCT06887192

ML-007C-MA for psychosis associated with Alzheimer’s disease

About this titleRead the official source — NCT06887192
Official study title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis

Recruiting in France
SchizophreniaMedication studyAges 55–90
Countries
France, United States, Canada, + 12 others
Sponsor
MapLight Therapeutics
Drug study icon
RecruitingNCT06929273

Long-term safety of KarXT in bipolarity type I

What is this study about?

This extension study evaluates the long-term safety and tolerability of KarXT for mania or mania with mixed features in people living with bipolarity type I.

Recruiting in France
BipolarityMedicationAges 18–65
Countries
France, United States, Australia, + 17 others
Sponsor
Bristol-Myers Squibb (Pharmaceutical company)
Drug study icon
RecruitingNCT06585787

KarXT or placebo for psychosis in Alzheimer’s disease

About this titleRead the official source — NCT06585787
Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Recruiting in France
SchizophreniaMedication studyAges 55–90
Countries
France, United States, Belgium, + 21 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingNCT07140913

KarXT with lithium, valproate, or lamotrigine for mania in bipolarity

About this title

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Read the official source — NCT07140913
What is this study about?

Researchers compare KarXT with placebo, each added to lithium, valproate or lamotrigine, in people with bipolarity type I experiencing mania, with or without mixed features. They want to know whether adding KarXT improves manic symptoms and assess its safety.

Recruiting in France
BipolarityMedication studyAges 18–65
Countries
France, United States, Argentina, + 10 others
Sponsor
Bristol-Myers Squibb (Pharmaceutical company)
Other study type icon
RecruitingNCT05361603

Acceptability of combined hepatitis and HIV screening in community settings

About this titleRead the official source — NCT05361603
Official study title

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Facilities "Outside the Walls" Using the Dual Screening Method TROD (Rapid Diagnostic Tests) and FibroScan

Recruiting in France
AddictionObservational studyAges 18+
Countries
France
Sponsor
University Hospital, Limoges

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.